/oss/taxonomy/term/3805/all en /oss/article/medical-contributors/we-know-about-type-1-and-type-2-diabetes-what-type-3-diabetes <p>The incidence of diabetes mellitus has reached epidemic levels in recent years, affecting one in every 10 adults globally in 2021. Ninety percent of these individuals have Type 2 Diabetes (T2D) which is characterized by two defects, namely resistance to the metabolic actions of insulin in combination with an inability of the pancreatic islet beta-cells to secrete enough insulin to overcome this resistance. T2D is also often associated with overweight or obesity, which plays a role in the development of the insulin resistance.</p> Fri, 12 Apr 2024 13:25:03 +0000 Patricia Brubaker, Ph.D., F.R.S.C. 9907 at /oss /oss/article/medical/hype-hope-and-leqembi <p>The word “qembi” roughly translates as beautiful, elegant or healthy and was somewhat ambitiously chosen as the root for “Leqembi,” the Alzheimer’s disease drug that recently made a big media splash thanks to receiving “accelerated approval” by the U.S. Food and Drug Administration, the first regulatory agency in the world to do so.</p> Wed, 11 Jan 2023 11:00:00 +0000 Joe Schwarcz PhD 9356 at /oss